Control Bionics Limited (CBL.AX)
AUD 0.06
(-1.69%)
AUD 0.06
(-1.69%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 | -5.91 Million AUD | -5.02% |
| 2023 | -5.63 Million AUD | 7.84% |
| 2022 | -6.11 Million AUD | -45.91% |
| 2021 | -4.18 Million AUD | -316.48% |
| 2020 | -1 Million AUD | 47.95% |
| 2019 | -1.93 Million AUD | -98.64% |
| 2018 | -972.45 Thousand AUD | -103.27% |
| 2017 | 29.74 Million NZD | -16.19% |
| 2016 | 35.48 Million NZD | 0.0% |
| 2015 | - NZD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q4 | -1.86 Million AUD | 0.0% |
| 2024 Q3 | -1.86 Million AUD | 15.0% |
| 2024 FY | -5.91 Million AUD | -5.02% |
| 2024 Q1 | -1.17 Million AUD | 55.34% |
| 2024 Q2 | -2.19 Million AUD | -86.49% |
| 2023 Q1 | -1.71 Million AUD | 42.26% |
| 2023 FY | -5.63 Million AUD | 7.84% |
| 2023 Q2 | -3 Million AUD | -74.93% |
| 2023 Q4 | -2.62 Million AUD | -87.12% |
| 2023 Q3 | -1.4 Million AUD | 53.17% |
| 2022 FY | -6.11 Million AUD | -45.91% |
| 2022 Q4 | -2.97 Million AUD | 0.0% |
| 2021 FY | -4.18 Million AUD | -316.48% |
| 2020 FY | -1 Million AUD | 47.95% |
| 2019 FY | -1.93 Million AUD | -98.64% |
| 2018 FY | -972.45 Thousand AUD | -103.27% |
| 2017 FY | 29.74 Million NZD | -16.19% |
| 2016 FY | 35.48 Million NZD | 0.0% |
| 2016 Q4 | 7.43 Million NZD | 0.0% |
| 2016 Q3 | 7.43 Million NZD | 0.0% |
| 2016 Q2 | 7.43 Million NZD | -16.19% |
| 2016 Q1 | 8.87 Million NZD | 0.0% |
| 2015 Q2 | 8.87 Million NZD | 0.0% |
| 2015 Q4 | 8.87 Million NZD | 0.0% |
| 2015 Q3 | 8.87 Million NZD | 0.0% |
| 2015 FY | - NZD | 0.0% |
| 2015 Q1 | - NZD | 0.0% |
| 2014 Q2 | - NZD | 0.0% |
| 2014 Q4 | - NZD | 0.0% |
| 2014 Q3 | - NZD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| 4DMedical Limited | -35.97 Million AUD | 83.563% |
| Adherium Limited | -10.22 Million AUD | 42.159% |
| Aroa Biosurgery Limited | -9.74 Million AUD | 39.335% |
| Atomo Diagnostics Limited | -6.84 Million AUD | 13.64% |
| Anteris Technologies Ltd | -67.33 Million AUD | 91.217% |
| CardieX Limited | -6.76 Million AUD | 12.587% |
| Compumedics Limited | -338 Thousand AUD | -1649.639% |
| Cochlear Limited | 356.8 Million AUD | 101.657% |
| CleanSpace Holdings Limited | -3.12 Million AUD | -89.111% |
| Cyclopharm Limited | -4.7 Million AUD | -25.804% |
| EMVision Medical Devices Ltd | -2.72 Million AUD | -116.653% |
| Nova Eye Medical Limited | -8.79 Million AUD | 32.722% |
| HeraMED Limited | -6.78 Million AUD | 12.823% |
| Imricor Medical Systems, Inc. | -22.62 Million AUD | 73.863% |
| ImpediMed Limited | -19.79 Million AUD | 70.117% |
| InhaleRx Limited | -1.44 Million AUD | -309.748% |
| LBT Innovations Limited | -3.74 Million AUD | -58.122% |
| Micro-X Limited | -9.76 Million AUD | 39.439% |
| Neurotech International Limited | -5.06 Million AUD | -16.66% |
| OncoSil Medical Limited | -11.91 Million AUD | 50.361% |
| PolyNovo Limited | 5.26 Million AUD | 212.408% |
| Respiri Limited | -7.12 Million AUD | 17.049% |
| SomnoMed Limited | -12.24 Million AUD | 51.692% |
| Universal Biosensors, Inc. | -6.74 Million AUD | 12.279% |
| Uscom Limited | -2.07 Million AUD | -185.036% |
| Visioneering Technologies, Inc. | -5.06 Million AUD | -16.797% |